Musculoskeletal News and Research RSS Feed - Musculoskeletal News and Research

Osteocyte study in space: Researchers to analyze effects of microgravity on osteocyte cultures

Osteocyte study in space: Researchers to analyze effects of microgravity on osteocyte cultures

Researchers may be "excyted" to learn that osteocyte cultures are headed to the International Space Station this spring for the first time. With their delivery on the next SpaceX commercial resupply services mission this month, the Osteocytes and mechano-transduction (Osteo-4) investigation team will analyze the effects of microgravity on this type of bone cell. [More]
Pharmacyclics announces positive results from IMBRUVICA Phase II study in WM patients

Pharmacyclics announces positive results from IMBRUVICA Phase II study in WM patients

Pharmacyclics, Inc. today announced longer-term data from a Phase II investigator-initiated study showing Waldenstrom's macroglobulinemia (WM) patients treated with IMBRUVICA (ibrutinib) experienced sustained disease control with an overall response rate (ORR) of 91% after a median of 19.1 months of treatment and a 2-year overall survival (OS) rate of 95%. [More]
Incidence, costs of osteoporotic fractures in China to double by 2035

Incidence, costs of osteoporotic fractures in China to double by 2035

The results of the first study using a health economics model to project osteoporosis-related fractures and costs for the Chinese population, shows that the country's healthcare system will face a dramatic rise in costs over the next few decades. [More]
Deep brain stimulation reduces PD pain severity but does not prevent it

Deep brain stimulation reduces PD pain severity but does not prevent it

Subthalamic nucleus deep brain stimulation has a beneficial effect on pain severity in patients with Parkinson’s disease that persists for up to 8 years, say researchers, but new onset of musculoskeletal pain in many suggests its effects are not enduring. [More]
Scientists identify small RNA molecule that can suppress cancer-causing genes in GBM

Scientists identify small RNA molecule that can suppress cancer-causing genes in GBM

Northwestern Medicine scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma mulitforme (GBM), a deadly and incurable type of brain tumor. [More]
Astellas Pharma, Medivation announce topline results from enzalutamide Phase 2 STRIVE trial

Astellas Pharma, Medivation announce topline results from enzalutamide Phase 2 STRIVE trial

Astellas Pharma Inc. and Medivation, Inc. today announced topline results from the Phase 2 STRIVE trial comparing enzalutamide with bicalutamide in a study population of men with non-metastatic or metastatic castration-resistant prostate cancer. [More]
BME announces launch of Speed Titan Nitinol Bone Fixation Implant

BME announces launch of Speed Titan Nitinol Bone Fixation Implant

BioMedical Enterprises announced the launch of the Speed Titan Nitinol Bone Fixation Implant today. As the newest addition to the BME Speed Fixation System, the Speed Titan joins the BME Speed, Speed Arc and Speed Shift™ implants to create the world's most comprehensive family of continuous active compression Nitinol implants. [More]
FLS could reduce healthcare costs associated with osteoporotic fractures

FLS could reduce healthcare costs associated with osteoporotic fractures

Using a simulation model, Swedish researchers have shown that the implementation of Fracture Liaison Services (FLS) could considerably reduce the human and healthcare costs associated with osteoporotic fractures. The results from the model were presented today at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases in Milan. [More]
Study demonstrates abnormal vitamin D levels in more than one-third of elite NCAA Division I athletes

Study demonstrates abnormal vitamin D levels in more than one-third of elite NCAA Division I athletes

A new study presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons found that more than one-third of elite, Division I college athletes may have low levels of vitamin D, which is critical in helping the body to absorb calcium needed to maintain bone mass, and to minimize musculoskeletal pain and injury risk. [More]
New study estimates UK hospital costs of hip fracture

New study estimates UK hospital costs of hip fracture

A new study presented today at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases reveals the high cost of first and subsequent hip fractures to the healthcare system in the UK. [More]
Top experts focus on musculoskeletal disorders in open key Congress in Milan

Top experts focus on musculoskeletal disorders in open key Congress in Milan

Musculoskeletal conditions, which affect over 1.7 billion people worldwide, will be the focus of a major four-day Congress which opens today in Milan, Italy. [More]
Bariatric surgery prior to joint replacement improves outcomes in obese patients

Bariatric surgery prior to joint replacement improves outcomes in obese patients

Obesity is not only a risk factor for developing knee and hip arthritis. It is also linked to less favorable outcomes after joint replacement surgery. [More]
Arthritis & Osteoporosis NSW to hold Clinical Update for 2015 for health professionals

Arthritis & Osteoporosis NSW to hold Clinical Update for 2015 for health professionals

Arthritis is a condition that affects over 1.1 million people in NSW and over 3 million people across Australia and with an ageing population, that figure is projected to reach 7 million by 2050. Arthritis is a condition which affects people across all ages, backgrounds, men and women alike. [More]
DePuy Synthes adds four new products to adult deformity portfolio

DePuy Synthes adds four new products to adult deformity portfolio

DePuy Synthes Companies announced the addition of four new products to its adult deformity portfolio as well as a new education offering, continuing its expansion of one of the broadest spine portfolios in the industry. The products were displayed by DePuy Synthes Spine at the 81st annual meeting of the American Academy of Orthopaedic Surgeons. [More]
HSS study examines racial and socioeconomic disparities in hip fracture care

HSS study examines racial and socioeconomic disparities in hip fracture care

A study by researchers at Hospital for Special Surgery (HSS) finds that people in certain racial and socioeconomic groups are at a disadvantage when it comes to care they receive after fracturing a hip. [More]
Hip replacement procedure alleviates pain, improves function in young JIA patients

Hip replacement procedure alleviates pain, improves function in young JIA patients

Hip replacement is often performed in patients with juvenile arthritis when their joints have been severely damaged by the disease. [More]
OrthoSensor raises $19 million in Series C Preferred Stock financing

OrthoSensor raises $19 million in Series C Preferred Stock financing

OrthoSensor, Inc., the leader in Sensor-Assisted Surgery, announced today that it has raised $19 million in a private placement of Series C Preferred Stock. Bridger Healthcare, Ltd. and The Tullis Growth Fund, L.P. participated in the round. The proceeds will be used to drive the commercialization of VERASENSE, OrthoSensor's leading product, and expand product development activities. [More]
Mutations in hair keratins increase risk for dental defects, caries

Mutations in hair keratins increase risk for dental defects, caries

Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher Olivier Duverger, National Institutes of Health-National Institute of Neurological Disorders and Stroke, Bethesda, Md., USA, will present a study titled "Hair Keratins as Structural Organic Components of Mature Enamel: The Link Between Hair Disorders and Susceptibility to Dental Caries." [More]

Discovery raises potential of blood test that can help diagnose osteoarthritis, rheumatoid

The first blood test for osteoarthritis could soon be developed, thanks to research by the University of Warwick. [More]
New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

Pharmacyclics, Inc. today announced that new pre-clinical and clinical data for ibrutinib (IMBRUVICA) will be highlighted at the 2015 American Association for Cancer Research Annual Meeting to be held April 18 – 22, 2015, in Philadelphia, PA. [More]
Advertisement
Advertisement